In response to the imperative need for quality supplies to be available for donors, governments, and other agencies to buy, this workstream—a collaboration with the Systems Strengthening Working Group—seeks to help manufacturers of generic supplies who currently have little knowledge of what to do and where to go to negotiate the necessary steps to ensure their products meet appropriate quality standards and to get their products to market.

The workstream focuses on:

• Pre-qualification of a range of hormonal contraceptive (HC) products under the WHO prequalification scheme
• Through the Innovation Fund-financed AQAS Initiative, the MDAWG is working on the provision of technical and strategic assistance to a selection of generic manufacturers of HC products who are relatively better placed to meet and maintain the standards required to achieve WHO prequalification. 
• Setting out and then implementing, in collaboration with the SSWG, a strategic plan to raise the interest of generic manufacturers of HC products in achieving WHO prequalification for one or more of their products.  

Expansion of this workstream: Matters that are connected to the overall concept of quality and efficacy of reproductive health supplies may also be addressed as a logical extension of this workstream.  These matters relate to the question of counterfeit goods and their proliferation in low- to middle-income countries, especially if they are hormonal contraceptive methods.